tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating for Rocket Pharmaceuticals: Strategic Progress and Strong Financial Position Drive Positive Outlook
PremiumRatingsBuy Rating for Rocket Pharmaceuticals: Strategic Progress and Strong Financial Position Drive Positive Outlook
4M ago
Rocket Pharmaceuticals Reports Q3 2025 Financial Results
Premium
Company Announcements
Rocket Pharmaceuticals Reports Q3 2025 Financial Results
4M ago
Rocket Pharmaceuticals reports Q3 EPS (45c), consensus (52c)
Premium
The Fly
Rocket Pharmaceuticals reports Q3 EPS (45c), consensus (52c)
4M ago
Cautious Hold Rating on Rocket Pharmaceuticals Amid Kresladi Developments and Danon Disease Uncertainty
PremiumRatingsCautious Hold Rating on Rocket Pharmaceuticals Amid Kresladi Developments and Danon Disease Uncertainty
4M ago
Rocket Pharmaceuticals’ FDA Resubmission for KRESLADI™ Accepted
Premium
Company Announcements
Rocket Pharmaceuticals’ FDA Resubmission for KRESLADI™ Accepted
4M ago
Rocket Pharmaceuticals announces FDA acceptance of Kresladi BLA resubmission
Premium
The Fly
Rocket Pharmaceuticals announces FDA acceptance of Kresladi BLA resubmission
4M ago
Hold Rating on Rocket Pharmaceuticals Amid Strategic Shifts and Regulatory Challenges
PremiumRatingsHold Rating on Rocket Pharmaceuticals Amid Strategic Shifts and Regulatory Challenges
5M ago
Rocket Pharmaceuticals withdraws BLA for Fanskya
Premium
The Fly
Rocket Pharmaceuticals withdraws BLA for Fanskya
5M ago
Rocket Pharmaceuticals Withdraws FDA Application for Gene Therapy
Premium
Company Announcements
Rocket Pharmaceuticals Withdraws FDA Application for Gene Therapy
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100